Biosynthetic gene clusters – Page 3

Discovery of the antifungal compound ilicicolin K through genetic activation of the ilicicolin biosynthetic pathway in Trichoderma reesei

mycolabadmin

Scientists used genetic engineering to activate a dormant gene cluster in the fungus Trichoderma reesei, enabling it to produce the antifungal compound ilicicolin H in high quantities. During this process, they discovered a new related compound called ilicicolin K that shows even stronger antifungal properties. These compounds could potentially overcome limitations of current antifungal treatments, especially against drug-resistant fungi like Candida auris.

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists have discovered a special bacterium called Streptomyces formicae that lives with ants in African acacia trees and produces powerful antibiotics. This bacterium naturally makes compounds called formicamycins that can kill dangerous antibiotic-resistant bacteria like MRSA, as well as antifungal compounds. Researchers are using advanced gene-editing techniques to unlock more hidden antimicrobial compounds from this bacterium’s genome, which could lead to discovering new medicines to treat infections.

A mass spectrometry-based strategy for investigating volatile molecular interactions in microbial consortia: unveiling a Fusarium-specific induction of an antifungal compound

mycolabadmin

Scientists developed a new method to study how different fungi communicate and compete with each other through invisible chemical signals called volatile organic compounds. By growing three types of fungi together in a controlled setup, they discovered that Fusarium culmorum specifically produces a compound called γ-terpinene when in contact with other fungi. This compound acts as a natural antifungal agent, helping Fusarium fight off competing fungi. This research provides a blueprint for understanding complex fungal interactions in environments like human lungs and could eventually help diagnose or prevent fungal-related diseases.

Rediscovery of viomellein as an antibacterial compound and identification of its biosynthetic gene cluster in dermatophytes

mycolabadmin

Researchers discovered that dermatophytes, fungi that cause common skin infections like athlete’s foot, produce a red pigment called viomellein that kills bacteria. By studying the genes responsible for making this compound, scientists found that most dermatophytes produce it, which may help explain how these fungi establish infections on skin despite the presence of protective bacteria. This discovery opens new possibilities for understanding skin infections and potentially developing new treatments.

Tracing the Origin and Evolution of the Fungal Mycophenolic Acid Biosynthesis Pathway

mycolabadmin

Scientists studied how different fungal species produce mycophenolic acid, a drug used to prevent transplant rejection in millions of patients worldwide. By analyzing the genomes of many fungal species, they found that only a few fungi can make this important drug, and they discovered that these fungi have different ways of protecting themselves from being poisoned by their own medicine. This research helps us understand how fungi evolve to produce valuable medicines and could lead to better ways to produce immunosuppressants.

Genomic characterization and fermentation study of the endophyte Stemphylium sp. (Aa22), a producer of bioactive alkyl-resorcinols

mycolabadmin

Scientists sequenced the complete genome of a fungus called Stemphylium sp. (strain Aa22) that lives inside wormwood plants without harming them. This fungus produces natural compounds called alkyl-resorcinols that can repel aphids and kill plant-damaging nematodes, making them potentially useful as organic pesticides. The researchers found the genetic instructions for making these compounds and determined that growing the fungus in liquid culture produces more of the useful compounds than growing it on rice, offering a promising path toward developing these natural biopesticides on a larger scale.

Microbe Profile: Streptomyces formicae KY5: an ANT-ibiotic factory

mycolabadmin

Scientists discovered a special bacterium called Streptomyces formicae living in ant nests in Africa that produces powerful antibiotics effective against dangerous drug-resistant bacteria and fungi. This bacterium has the genetic potential to make at least 45 different antimicrobial compounds, though most are not currently being produced under standard laboratory conditions. Using advanced gene-editing techniques like CRISPR, researchers are working to activate these hidden pathways to discover new medicines. This research demonstrates how exploring bacteria in nature can lead to finding new antibiotics to treat serious infections.

The First Whole Genome Sequence and Methylation Profile of Gerronema lapidescens QL01

mycolabadmin

Researchers sequenced the complete genome of Lei Wan (Gerronema lapidescens), a medicinal mushroom used in Chinese traditional medicine for treating parasites and digestive issues. The study reveals the mushroom’s genetic makeup, including 15,847 genes and over 3 million methylation marks that may control gene expression. They identified 67 gene clusters that could produce medicinal compounds and 521 enzymes for breaking down organic matter. This genetic blueprint will help scientists understand how to cultivate this threatened species sustainably and develop its health benefits.

Phylogenetic and functional diversity among Drosophila-associated metagenome-assembled genomes

mycolabadmin

Researchers used advanced sequencing techniques to study the bacteria living in wild fruit flies collected from three continents. They discovered that these flies host diverse communities of bacteria that produce various compounds potentially beneficial to the fly, including antimicrobial molecules and metabolites that may help with nutrition and disease resistance. The study reveals that wild fly microbiomes are much more complex than previously understood from laboratory studies.

Genome-Mining Based Discovery of Pyrrolomycin K and L from the Termite-Associated Micromonospora sp. RB23

mycolabadmin

Researchers discovered two new antimicrobial compounds called pyrrolomycins from a bacterium found in termite guts using genome analysis and advanced chemistry techniques. These compounds are modified versions of known antimicrobial molecules, featuring halogenated structures. Interestingly, the bacteria appears to protect itself from its own toxic compounds through chemical modifications, a strategy that researchers believe could inform the design of new antibiotics to combat drug-resistant bacteria.

Research Topic: Biosynthetic gene clusters